Important Safety
Information

Indications for Use: AviClear is FDA cleared for the long-term treatment of mild to severe inflammatory acne vulgaris.

Contraindications: Pregnant patients and patients undergoing treatment for skin cancer.

Important Safety Information: The following treatment-related side effects may occur during or after treatment with AviClear: Discomfort, erythema and edema, transient acne flareups, temporary skin dryness, blisters, crusting/scabbing, hyperpigmentation, skin texture changes, infection, scarring, hypopigmentation and altered hair growth.

Warnings: Do not use topical anesthetic with AviClear treatments; do not treat over dysplastic nevi or questionable pigmented lesions; do not treat over or close to tattoos or permanent make-up.

Precautions: Use caution when treating patients with any of the following: current or recent use of Isotretinoin (Accutane/Roaccutane), current or recent use of anticoagulants, presence of any inflammatory skin condition other than acne in the target area, history of malignant tumors in the target area, history of coagulopathies, history of keloids or hypertrophic scarring, history of vitiligo or pigmentary disorders, history of herpes – pre-treatment with an antiviral may be indicated, open lesions or wounds – treatment should only be performed on intact skin, metal or electronic implants – reaction to treating over implants is unknown; check with implant manufacturer or physician managing the implant before treating. The AviClear Laser System has not been studied on the lips, upper and lower eyelids, and eyebrows. Refer to the Operator Manual to view the laser safety labels of the product.